Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolated lung perfusion with melphalan followed by pulmonary metastasectomy in resectable pulmonary metastases
2006-002808-34Phase 2Active
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan in colorectal cancer (CRC), soft tissue sarcoma (STS) and osteosarcoma (OS), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Time to progression or disease-free interval. Started Aug 2009; status: active.
02
Drugs
melphalan
03
Conditions
colorectal cancer (CRC)soft tissue sarcoma (STS)osteosarcoma (OS)
Beyond the preview
Go deeper on 2006-002808-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002808-34.